{"id":211200,"name":"CEPHEID","slug":"cepheid","state":"CA","country":"United States of America","description":"Diagnostic testing","totalSpending":780000,"filings":15,"yearlySpending":[{"year":2021,"income":150000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":150000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["BROWNSTEIN HYATT FARBER SCHRECK, LLP"],"lobbyists":["ALFRED MOTTUR","DAVID COHEN","CARMENCITA WHONDER","MARC LAMPKIN","ELIZABETH MAIER","BRIAN WILD","BRIAN MCKEON","NADEAM ELSHAMI","EMILY FELDER","ARI ZIMMERMAN","LAURA BOLLIER","SAMANTHA CARL-YODER","ADAM STEINMETZ","SAGE SCHAFTEL","RUSSELL SULLIVAN","ANDREW USYK","DAVID REID","DEEMA TARAZI","ZACHARY PFISTER","GREGORY SUNSTRUM","THOMAS MOTTUR"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office","State, Dept of (DOS)","Natl Institutes of Health (NIH)","Executive Office of the President (EOP)"],"sampleDescriptions":["Issues related to COVID-19 - American Rescue Plan Implementation;\nIssues related to diagnostic testing;\nIssues related to the Strategic National Stockpile, supply chain,  and future pandemic preparedn","Issues related to diagnostic testing and reimbursement related to COVID testing.","Issues related to COVID-19 - American Rescue Plan Implementation\nIssues related to diagnostic testing\nIssues related to the Strategic National Stockpile, supply chain,  and future pandemic preparednes","Issues related to COVID-19 - American Rescue Plan Implementation\nIssues related to diagnostic testing and reimbursement related to COVID testing\nIssues related to the Strategic National Stockpile, sup","Issues related to COVID-19 - American Rescue Plan Implementation\nIssues related to diagnostic testing and reimbursement related to COVID testing\nIssues related to the Strategic National Stockpile, sup"]}